Donate Now
  • What We've Learned
A New Colour-Coded Imaging Method to Diagnose Gout
Osteoarthritis-6.0-1
Scientific Study Title:
Research Category
Tags

Why did we do this research?

Gout is a very painful type of arthritis that involves a build up of crystals (tophi) within the joints. Unfortunately, the only way that doctors can currently diagnose gout is to draw fluid from an inflamed joint, which can be quite painful and is often not very accurate. Recently, a new body scanner called Dual Energy CT (DECT) has been shown to produce easy-to-read images of gout that actually colour-code the tophi in green, offering the potential to quickly diagnose gout without having to tap into a joint. This study aimed to determine how well DECT can diagnose gout compared to the old method.

What did we do?

We asked 80 volunteers with gout or other types of arthritis to come by the Vancouver General Hospital to get DECT scans of their arms and legs. We found:

  • DECT was accurately able to determine whether volunteers had gout or another type of arthritis
  • Scans are easy to interpret by any trained professionals, as two radiologists who read the scans came to the same conclusions
  • DECT was able to determine how severe the crystal build-up was among volunteers with gout

The Research Team

Principal Investigator

  • Hyon Choi, MD, DrPH, FRCPC, Research Scientist, Rheumatology, Arthritis Research Canada (University of British Columbia)

Co-investigators

  • Lindsay C. Burns, BSc Kamran Shojania , MD Nicole Koenig, BA Graham Reid, MB ChB Mohammed Abufayyah, MD Genevieve Law, MD Alison S. Kydd, MD PhD Hugue Ouellette, MD Savvas Nicolaou, MD

Who Funded This Research?

This was an industry-sponsored project, with funding from Takeda Pharmaceuticals Inc.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More